Загрузка...
Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2/STAT3/SOCS1 Signaling Pathway
Ulcerative colitis (UC) is a refractory chronic disease characterized by bloody diarrhea and mucosal or submucosal ulcers. There is an urgent need of new drugs for the treatment of ulcerative colitis. EHLJ7 is a quaternary coptisine derivative. Herein, we explored the therapeutic effect of EHLJ7 on...
Сохранить в:
| Опубликовано в: : | Front Pharmacol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6987075/ https://ncbi.nlm.nih.gov/pubmed/32038241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01553 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|